术中右美托咪定对术后认知功能下降影响的多中心随机对照试验
本研究为多中心随机对照试验,纳入535例65岁及以上择期胃肠剖腹手术患者,随机接受术中右美托咪定(0.5 μg.kg-1负荷后0.4 μg.kg-1.hr-1输注)或安慰剂。结果显示右美托咪定降低术后第3天、第7天及第1个月的认知障碍发生率,且术后第7天认知障碍与术后第3天和第7天血清脑源性神经营养因子浓度变化相关。
要点
- 术中右美托咪定可降低老年胃肠剖腹手术患者术后1个月内的认知障碍发生率。
- 术后第7天认知障碍与术后第3天和第7天血清BDNF浓度变化相关。
- 右美托咪定组与安慰剂组在术后第3天、第7天和第1个月的认知障碍发生率差异均有统计学意义。
核心结论
- 术中右美托咪定降低老年择期剖腹手术患者术后1个月内的认知功能下降,并与血清BDNF浓度变化相关。
研究设计与样本
- 多中心随机对照试验,纳入535例65岁及以上择期胃肠剖腹手术患者,随机分为右美托咪定组(n=269)和安慰剂组(n=266)。
主要发现
- 术后第3天认知障碍发生率:右美托咪定组40/269 vs 安慰剂组65/266,p=0.006。
- 术后第7天认知障碍发生率:右美托咪定组31/269 vs 安慰剂组49/266,p=0.03。
- 术后第1个月认知障碍发生率:右美托咪定组42/250 vs 安慰剂组61/248,p=0.04。
- 术后第7天认知障碍与术后第3天BDNF浓度变化的ROC曲线下面积为0.63(p<0.001),与术后第7天BDNF浓度变化的ROC曲线下面积为0.58(p=0.016)。
临床怎么用
- 对于65岁及以上择期胃肠剖腹手术患者,可考虑术中给予右美托咪定(0.5 μg.kg-1负荷后0.4 μg.kg-1.hr-1输注)以降低术后认知障碍风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Peri-operative dexmedetomidine can reduce rates of delirium immediately after surgery. We aimed to assess the effect of dexmedetomidine on cognition up to six postoperative months and its association with changes in serum concentrations of brain-derived neurotrophic factor on the third and seventh postoperative days. We randomly allocated 535 patients aged 65 years or more undergoing scheduled gastro-intestinal laparotomy to: intra-operative dexmedetomidine, 0.5 μg.kg-1 bolus followed by 0.4 μg.kg-1 .hr-1 infusion (n = 269), or placebo (n = 266). Dexmedetomidine reduced the rate of cognitive impairment: on the third postoperative day, 40/269 vs. 65/266, p = 0.006; on the seventh postoperative day, 31/269 vs. 49/266, p = 0.03 and at one postoperative month, 42/250 vs. 61/248, p = 0.04. Cognitive impairment at seven postoperative days was associated with changes in brain-derived neurotrophic factor concentrations on the third and seventh postoperative days; area under the receiver operating characteristic curve 0.63, p < 0.001 and 0.58, p = 0.016, respectively. Intra-operative dexmedetomidine reduced cognitive decline up to one postoperative month in elderly patients undergoing scheduled laparotomy, which was associated with changes in serum brain-derived neurotrophic factor.
引用
- Cheng XQ, Mei B, Zuo YM, et al. A multicentre randomised controlled trial of the effect of intra-operative dexmedetomidine on cognitive decline after surgery. Anaesthesia. 2019. PMID: 30835822. doi:10.1111/anae.14606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。